Description

GW0742 is a PPARβ/δ agonist that has been shown to improve glucose homeostasis and insulin sensitivity in diabetic rats, as well as increase fat loss. Treatment with GW0742 has also been shown to improve dyslipidemia and hyperglycemia in diet-induced obese mice. The activation of PPARβ/δ by GW0742 leads to enhanced circadian rhythm, which affects behaviour, sleep cycle and some functions related to increment in energy production.

GW0742
CAS Number	317318-84-6
Molar Mass	471.48g.mol-1
Chemical Formula	C21H17F4NO3S2
IUPAC Name	2-[4-[[2-[3-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-1,3-thiazol-5-yl]methylsulfanyl]-2-methylphenoxy]acetic acid

SR9011
CAS Number	1379686-29-9
Molar Mass	479.04 g·mol−1
Chemical Formula	C23H31ClN4O3S
IUPAC Name	3-[[(4-chlorophenyl)methyl-[(5-nitrothiophen-2-yl)methyl]amino]methyl]-N-pentylpyrrolidine-1-carboxamide